The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Dec. 10, 2019

Filed:

Mar. 11, 2016
Applicant:

Lanthiopep B.v., Groningen, NL;

Inventor:

Anneke Kuipers, Haule, NL;

Assignee:

LANTHIOPEP B.V., Groningen, NL;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 38/00 (2006.01); C07K 14/575 (2006.01); A61K 47/54 (2017.01); A61K 38/22 (2006.01); C07K 1/04 (2006.01); C07K 1/107 (2006.01);
U.S. Cl.
CPC ...
C07K 14/575 (2013.01); A61K 38/22 (2013.01); A61K 47/549 (2017.08); C07K 1/04 (2013.01); C07K 1/1075 (2013.01); C07K 2319/02 (2013.01); C07K 2319/50 (2013.01);
Abstract

The invention generally relates to the field of medicine and pharmacology. More particularly, it relates to novel analogs of galanin, and the use thereof in therapy. Provided is a cyclic peptide analog of galanin, wherein the galanin analog comprises a (methyl)Lanthionine bridge and wherein the analog has the general formula 'X1-X2-X3-X4-X5-X6-X7-X8-X9-X10-X11-X12-X13-X14-X15-X16-X17-X18-X19-X20-X21-X22-', or a truncated variant thereof lacking X1 and/or up to 11 of the C-terminal residues, wherein two residues selected from the group consisting of X3, X4, X6, X7, X10 and X13-X19 together form a Lanthionine bridge of the structure Ala-S-Ala, or a methyl Lanthionine bridge of the structure Abu-S-Ala or Ala-S-Abu.


Find Patent Forward Citations

Loading…